Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sergio Rizzo

Looking for the Best Immune-Checkpoint Inhibitor in Pre-Treated NSCLC Patients: An Indirect Comparison Between Nivolumab, Pembrolizumab and Atezolizumab

International Journal of Cancer
Cancer ResearchOncology
2017English

EGFR Inhibition in NSCLC: New Findings…. And Opened Questions?

Critical Reviews in Oncology/Hematology
GerontologyGeriatricsHematologyOncology
2017English

Relapsing or Refractory Idiopathic Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: The Role of Rituximab

Transfusion
AllergyImmunologyHematology
2010English

Co-Expression of CD133+/CD44+in Human Colon Cancer and Liver Metastasis

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2012English

PML Expression in Soft Tissue Sarcoma: Prognostic and Predictive Value in Alkylating Agents/Antracycline-Based First Line Therapy

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2012English

PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2011English

Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules

Current Drug Metabolism
Clinical BiochemistryPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy